Influence of probiotics on Candida presence and IgA anti-Candida in the oral cavity

Brazilian Journal of Microbiology

Volumn 40, Issue 4, 2009, Pages 960-964

  dos Santos, Agda Lima ^a   Jorge, Ant̂nio Olavo Cardoso ^a   dos Santos, Silvana Soléo Ferreira ^a   e Silva, Célia Regina Gonçalves ^a   Leão, Mariella Vieira Pereira ^a  

^a UNIVERSITY OF TAUBATÉ   (Brazil)

Author keywords

Bifidobacterium; Candida; IgA; Lactobacillus casei

Indexed keywords

BIFIDOBACTERIUM; CANDIDA; CANDIDA ALBICANS; CANDIDA TROPICALIS; LACTOBACILLUS CASEI;

EID: 70350161511     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/s1517-83822009000400030     Document Type: Article

References (22)

1. Barousse, M.M.; Van Der Pol, B.J.; Fortenberry D.; Orr, D.; Fidel, P.L. JR. (2004). Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescents. Sex. Transm. Infect. 80(1), 48-53.
2. Biasoli, M.S.; Magaró, H.M. (2003). In vitro of carbohydrates and enteric bacteria on adherence of Candida albicans. Rev. Iberoam. Micol. 20(4), 160-163.
3. Boirivant, M.; Strober, W. (2007). The mechanism of action of probiotics Curr. Opin. Gastroenterol. 23(6), 679-692.
4. Fuller, R. (1989). Probiotics in man and animals. J. Appl. Bacteriol. 66(5), 365-78.
5. Gismondo, M.R.; Drago L.; Lombardi, A. (1999). Review of probiotics available to modify intestinal microflora. Int. J. Antimicrob. Agents 12(4), 287-292.
6. Mombelli, B.; Gismondo, M.R. (2000). The use of probiotics in medical practice. Int. J. Antimicrob. Agents. 16(4), 531-536.
7. Elahi, S.; Pang, G.; Ashman, R.; Clancy, R. (2005). Enhanced clearance of Candida albicans from the oral cavities of mice following oral administration of Lactobacillus acidophilus. Clin. Exp. Immun. 141, 29-36.
8. Hatakka, K.; Ahola, A.J.; Yli-Knuuttila, H.; Richardson, M.; Poussa, T.; Meurman, J.H.; Korpela, R. (2007). Probiotics reduce the prevalence of oral Candida in the Elderly - a randomized controlled Trial. J. Dent. Res. 86, 125-130.
9. Hickson, M.; D'Souza, A.L.; Muthu, N.; Rogers, T.R.; Want, S.; Raikumar, C.; Bulpitt, C.J. (2007). Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 335(10), 76-80.
10. Holmes, A.R.; Bandara, B.M.K.; Cannon, R.D. (2002). Saliva promotes C. albicans adherence to human epithelial cells. J. Dent. Res. 81(1), 28-32.
11. Jacobsen, C.N.; Nielsen, V.R.; Hayford, A.E.; Moller, P.L.; Michael Sen, K.F.; Paerregaard, A.; Sandström, B.; Tvede, M.; Jacobsen, M. (1999). Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strais in humans. Appl. Environ. Microbiol. 11(65), 4949-56.
12. Jeganathan, S.; Ufomata, D.; Hobkirk, J.A.; Ivanyi, L. (1987). Immunoglobulin A1 and A2 subclass of salivary antibodies to Candida albicans in patients with oral candidosis. Clin Exp Immunol. 70(2), 316-21.
13. Kantardjiev, T.V.; Popova, E.V. (2002). Anti-Candida antibodies in serum and saliva of patients with denture stomatitis. Folia Med (Plovdiv). 44(4), 39-44.
14. a ed) Princípios de Microbiologia e Imunologia. Editora Santos, São Paulo, Brazil.
15. Larsson P.G.; Stray-Pedersen, B.; Ryttig, K.R.; Larsen, S. (2008). Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health. 15, 8-3.
16. Matsuzaki, T.; Takagi, A.; Ikimura, H.; Matsuguchi, T.; Yokokura, T. (2007). Intestinal Microflora: probiotics and autoimmunity. J. Nutr. 137(3 suppl. 2), 798S-802S.
17. Pelto, L.; Isolauri, E.; Lilius, E.; Nuutila, Salmimen, S. (1998). Probiotic bacteria down-regulate the milk induced inflammatory response in milk hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin. Exper. Allergy. 28(12):1474-1479.
18. Velraeds, M.M.; Van Der Mei, H.C.; Reid, G.; Busscher, H.J. (1996). Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactants from Lactobacillus isolates. Appl. Env. Microbiol. 62(2), 1958-63.
19. Mombelll, B.; Gismondo, M.R. (2000). The use of probiotics in medical practice. Int. J. Antimicrob. Agents. 16(4), 531-536.
20. Vieira, J.D.G.; Ribeiro, E.L.; Campos, C.C.; Pimenta, F.C.; Toledo, O.A; Nagato, G.M.; Souza, N.A.; Ferreira, W.M.; Cardoso, C.G.; Dias, S.M.S; Araújo, C.A; Zatta, D.T.; Santos, J.S. (2005). Candida albicans isoladas da cavidade bucal de crianças com síndrome de Down: ocorrência e inibição do crescimento por Streptomyces sp Rev. Soc. Bras. Med. Trop. 38(5), 383-86.
21. Vudhichamnong, K.; Walker, D.M.; Ryley, H.C. (1982). The effect of secretory immunoglobulin A on the in-vitro adherence of the yeast C. albicans to human oral epithelial cells. Arch. Oral. Biol. 27(8), 617-21.
22. Wehkamp, J.; Harder, J.; Wehkamp, K.; Wehkamp-Von Meissner, B.; Schlee, M.; Enders, C.; Sonnenborn, U.; Nuding, S.; Bengmark, S.; Fellermann, K.; Schröder, J.M.; Sange, E.F. (2004). NF-KB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect. Immun. 10(72), 5750-58.